Topic: community driven neurology and brain health in Chicago
Dr. Lenny Cohen is a board certified neurologist with more than 18 years of clinical experience and the founder of CNS Center.
What this conversation covers
Dr. Cohen shares his journey as an independent neurologist in Chicago and how his curiosity driven approach lets him go beyond traditional care models. He discusses incorporating treatments such as hyperbaric oxygen therapy, neuromodulation, and IV infusions for conditions ranging from long COVID to stroke recovery and neurodegenerative disease.
He also describes his philosophy of reducing bureaucracy in medicine, which allows faster adoption of promising therapies, and he emphasizes collaboration with other providers so patients receive the most appropriate care. He closes on the future of neurology through biomarkers, EEG based diagnostics, and data driven treatment aimed at earlier detection and better outcomes.
If you or someone you know is navigating neurological conditions, chronic pain, or cognitive concerns, this conversation offers insight into a more personalized, forward thinking approach to care.
Highlights from the interview
Dr. Lenny Cohen: I am a solo neurologist working in Chicago for the last 18 years, and I enjoy the neurological curiosity that allows me to build out my practice on things that can or cannot be offered in bigger practices. We do not have bureaucracy. If I find something curious, or something research shows to be very promising, we will do that.
Hyperbaric medicine
Dr. Lenny Cohen: One of those was hyperbaric medicine, which I looked at about 10 years ago, and we became the first standalone center in Chicago that is a medical facility using hospital grade hyperbaric chambers. Part of the reason was personal. My father developed early onset dementia, and I was looking at other things outside of western medicine that might be helpful. We were doing hyperbaric for long COVID before the research articles were published, and we were very successful with that.
Neuromodulation
Dr. Lenny Cohen: I think we both agree that neuromodulation is the future of medicine, because we are hitting a roadblock with pharmaceuticals. Neuromodulation started with TMS, or transcranial magnetic stimulation, which has been on the market for about 20 years and FDA approved for about 10 for depression and obsessive compulsive disorder. But we use it for more than that. If you stimulate a specific area of the brain, you can make that area do something you want. If I stimulate the speech center, I can help people after stroke who are unable to talk recover their speech faster. If I stimulate motor cortex, in conjunction with physical therapy, it allows them to recover faster.
Dr. Lenny Cohen: More recently we went from central neuromodulation to peripheral neuromodulation with a magnetic peripheral nerve stimulator. It stimulates the peripheral nervous system for patients with chronic pain or neuropathy, and it has very promising research not just for diabetic neuropathy but for different types of pain.
The patients he sees
Dr. Lenny Cohen: Pretty much anything related to neurological pathology, we can try to help, ranging from headaches to stroke recovery, multiple sclerosis to Parkinson disease. And if we are not successful, which does happen, we can always send patients to colleagues at Northwestern or Rush University if they need more of a multidisciplinary approach.
Two locations and access
Dr. Lenny Cohen: We moved from Oak Park to River Forest and it allows us to be more a part of the community. There we offer our neurological services as well as TMS, and we have an IV infusion suite for patients with multiple sclerosis and for patients with dementia receiving anti amyloid medications.
Dr. Lenny Cohen: The one thing we did not talk about is the rather sad reality that patients need to wait months to be seen. I recently had a patient who had to wait six months to be seen by a specialist. Our patients are seen within two to four weeks.
Where neurology is going
Dr. Lenny Cohen: I am starting to look at biomarkers, at how we can identify a patient problem before it becomes a problem. Lately we found that a specific type of EEG evaluation can tell us whether a patient has had a traumatic brain injury, or whether they are prone to dementia at the time they develop mild cognitive impairment. That would let us have longitudinal analysis, compare apples to apples, and see whether patients respond favorably to TMS or to hyperbaric medicine. Being able to anchor to objectivity and simplify the story as much as possible is really important.
On working together
Dr. Lenny Cohen: This is very old school medicine, when colleagues talk to each other. Medicine nowadays is kind of faceless. We hide behind electronic medical records, and at best there is a comment in your inbox from a colleague. That is why we work well together, because we can develop a personal relationship, discuss our patients, and make a plan for how to help them.
Where to find Dr. Cohen
CNS Center, Chicago: 2219 W Belmont Ave, Chicago, IL 60618. River Forest: 7319 W North Avenue, River Forest, IL 60305.